Clinical Trial Update: Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and exploratory efficacy of Kanglaite Injection in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Kanglaite Injection (Kanglaite)

Snippet

Sponsor: KangLaiTe USA | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED